Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 2, 2016
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamideL M D Gonçalves, F Maestrelli, L Di Cesare Mannelli, et al.
Neuroscience|March 23, 2010
Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathyE Vivoli, L Di Cesare Mannelli, A Salvicchi, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|June 30, 2009
The endoscopic spectrum of segmental colitis associated with diverticulosisA Tursi, W Elisei, G Brandimarte, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Influence of ring size on the cognition-enhancing activity of DM235 and MN19, two potent nootropic drugsL Guandalini, E Martini, L Di Cesare Mannelli, et al.
Neuropharmacology|February 7, 2018
Environmental training is beneficial to clinical symptoms and cortical presynaptic defects in mice suffering from experimental autoimmune encephalomyelitisT Bonfiglio, G Olivero, M Vergassola, et al.
Neuropharmacology|January 18, 2018
Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathyF Resta, L Micheli, A Laurino, et al.
Biochemical Pharmacology|July 31, 2023
Persulfidation of mitoKv7.4 channels contributes to the cardioprotective effects of the H<sub>2</sub>S-donor Erucin against ischemia/reperfusion injuryL Testai, R Montanaro, L Flori, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 12, 2025
The dual role of VEGF-A in a complex in vitro model of oxaliplatin-induced neurotoxicity: Pain-related and neuroprotective effectsA Toti, E Lucarini, V Ferrara, et al.
Gut Microbes|September 15, 2023
Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry diseaseC Delprete, R Rimondini Giorgini, E Lucarini, et al.
Pageof 2